Skip to main content

Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia.

Journal articles  - Letter
Shyamsunder, P; Lee, KL; Chan, ZE; Chuah, C; Yu, M; Thever, HP; Nah, GSS; Sulaimi, FNB; Krishnan, V; Ong, ST
Published in: Leukemia
July 2026

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

July 2026

Volume

40

Issue

7

Start / End Page

1551 / 1555

Location

England

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shyamsunder, P., Lee, K. L., Chan, Z. E., Chuah, C., Yu, M., Thever, H. P., … Ong, S. T. (2026). Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia. Leukemia, 40(7), 1551–1555. https://doi.org/10.1038/s41375-026-02988-1
Shyamsunder, Pavithra, Kian Leong Lee, Zhu En Chan, Charles Chuah, Mengge Yu, Hari Priyaa Thever, Giselle Sek Suan Nah, Fatin Nasha Bte Sulaimi, Vaidehi Krishnan, and S Tiong Ong. “Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia.Leukemia 40, no. 7 (July 2026): 1551–55. https://doi.org/10.1038/s41375-026-02988-1.
Shyamsunder, Pavithra, et al. “Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia.Leukemia, vol. 40, no. 7, July 2026, pp. 1551–55. Pubmed, doi:10.1038/s41375-026-02988-1.
Shyamsunder P, Lee KL, Chan ZE, Chuah C, Yu M, Thever HP, Nah GSS, Sulaimi FNB, Krishnan V, Ong ST. Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia. Leukemia. 2026 Jul;40(7):1551–1555.

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

July 2026

Volume

40

Issue

7

Start / End Page

1551 / 1555

Location

England

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology